1 / 10

Presented by: Maureen Kirkman & Jim Ringer (Chairperson) 5 August 2008

Medicines and Related Substances Amendment Bill 2008 Pharmaceutical Task Group: Industry Marketing Code Steering Committee. Presented by: Maureen Kirkman & Jim Ringer (Chairperson) 5 August 2008. PTG – Pharmaceutical Industry Marketing Code Steering Committee 2007-2008.

farteaga
Download Presentation

Presented by: Maureen Kirkman & Jim Ringer (Chairperson) 5 August 2008

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Medicines and Related Substances Amendment Bill 2008Pharmaceutical Task Group:Industry Marketing Code Steering Committee Presented by: Maureen Kirkman & Jim Ringer (Chairperson) 5 August 2008

  2. PTG – Pharmaceutical Industry Marketing Code Steering Committee 2007-2008 • IMSA Innovative Medicines South Africa • NAPM National Association of Pharmaceutical Manufacturers • PHARMISA Pharmaceuticals made in South Africa • PIASA Pharmaceutical Industry Association of South Africa • SMASA Self Medication Association of South Africa • Supported by: • NAPW National Association of Pharmaceutical Wholesalers • IHD International Healthcare Distributors • PHD Pharmaceutical Healthcare Distributors • PSSA Pharmaceutical Society of SA This initiative to eliminate perversities is supported by the entire medicines supply chain

  3. Medicines and Related Substances Amendment Bill 2008 Background • Many perversities in the marketplace related to the marketing of medicines and other health products • In 1998 attempt to remove these for medicines by amendments [Sec 18A] banning incentives and required the Minister of Health to make Regulations for the marketing of medicines and to provide for an enforceable Code of Practice [Sec 18C] • We welcome the application of these measures to the marketing of all health products to eliminate perversities

  4. Legal Gaps and Marketing Code • There is no provision for regulations to support S18A and this is creating loopholes and opportunities to get around the ban on incentives • No direct legal link between the Medicine Pricing Regulations and marketing incentives • Marketing Code for Medicines not published in an enforceable form by DoH • No enforcement • Perversities continue in the marketing of medicines and other health products – undermines the intent of the Medicines Pricing Regulations

  5. Amendment Bill 2008 • Industry supports the elimination of perversities in the system [ Section 18A and 18C ] • Publication of a code/s is essential – but • The Bill changes wording from ‘the MoH “shall” to “may” make Regulations’ relating to a Code of Practice for marketing of health products. This change should not be made in the Bill Reason: • Compliance must be mandatory for all companies and for all products to protect patients • Compliance must be enforced through the legislation and registration processes

  6. Recommendation • Empowering provision needed for Regulations [Sec 35] to enforce compliance with the legislation [18A] and Marketing Codes [18C] • Code to be based on self-regulation by industry and supported by ultimate enforcement via the SAHPRA • Compliance with the code to be a condition for registration of a medicine or a health product • Publish SA Marketing Code for Medicines without delay and follow with relevant Codes of Marketing Practice for other health products

  7. Conclusion Our request: • Provide for regulations to S18A and S18C • Finalise and publish SA Marketing Codes • Step wise implementation of Code – medicines first • Objective is to ensure ethical marketing practices and eliminate perversity in the marketing of health products to protect patients

  8. Contacts • IMSA Val Beaumont 011 880 4644 • NAPM Raseela Inderlall 012 323 7529 • PHARMISA Stavros Nicolau 011 239 6798 • PIASA Maureen Kirkman 011 805 5100 • SMASA Allison Vienings 012 803 4444 • NAPW Trevor Phillips 083 378 3260 • IHD Murray Clark 011 458 2222 • PSSA Ivan Kotze 012 301 0833

  9. Marketing Code Authority Board of Management Structure of Code enforcement body Adjudication panel Adjudicator / Director Appeal Board Admin assistant

  10. Composition of Board Industry representatives – from companies and trade associations supporting the Codes Dept of Health Health professionals from HPCSA / SAPC Consumer representative

More Related